Your session is about to expire
← Back to Search
Advanced Monitoring Strategy for Severe Traumatic Brain Injury (BOOST3 Trial)
BOOST3 Trial Summary
This trial will help doctors determine whether a treatment strategy guided by both intracranial pressure and brain tissue oxygen is more effective than one guided by intracranial pressure alone.
BOOST3 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBOOST3 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BOOST3 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have an injury that cannot be survived.Your Glasgow Coma Scale (GCS) score is between 3 and 8 and was measured without using paralyzing drugs.I do not have an infection in my blood.I needed help with daily activities before my injury.My pupils do not respond to light and I am not on muscle relaxants.I have had a brain injury without an object going through my skull.My low blood pressure does not improve with treatment.Your blood oxygen levels are too low.I can have brain probes placed within 6 hours of getting to the hospital.If you have a low score on the Glasgow Coma Scale and need help breathing with a tube, you may not be able to participate in the study.You have a current drug or alcohol problem that could affect how your body responds to brain oxygen treatments.You cannot have a device placed inside your brain.I have a neurological condition that affects my movement or senses.I can have probes placed in my brain within 12 hours of injury.My brain oxygen levels have been treated before joining the study.I am 14 years old or older.You have signs of head injury on a CT scan.My body doesn't respond to treatments for low oxygen levels.
- Group 1: ICP only
- Group 2: ICP + PbtO2
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any opportunities still available to take part in this clinical experiment?
"Affirmative. The clinicaltrial.gov database states that this medical experiment, inaugural in late August 2019, is currently enrolling patients. 1094 individuals must be recruited from 35 distinct sites to successfully complete the trial."
How many test subjects are engaged in this experiment?
"As mandated by the inclusion criteria, 1094 willing participants are needed to complete this trial. Patients may sign up at Duke University Hospital in Durham or UPMC Presbyterian Hospital in Pittsburgh."
In what locations is this clinical experiment being conducted?
"The trial is taking place in an array of 35 sites which includes, but not limited to, Durham, Pittsburgh and Houston. For convenience purposes when signing up for the study it is recommended that you locate your nearest clinic to reduce travel time."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger